Alnylam Pharmaceuticals
ALNY
#660
Rank
S$49.95 B
Marketcap
S$374.16
Share price
0.62%
Change (1 day)
-6.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company